(Q34627034)

English

Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Emmanuel Sonnet

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Karine Lacut

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Nathalie Roudaut

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dominique Mottier

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Véronique Kerlan

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Emmanuel Oger

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

626-631

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Insulin-like growth factor-1 as a vascular protective factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Estrogen regulation of growth hormone action.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Signaling pathways activated by the growth hormone receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Gigantism in mice lacking suppressor of cytokine signalling-2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

The insulin-like growth factor-I system and hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02783.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2007.02783.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34627034&oldid=1557425494"